2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share
March 11, 2025
March 11, 2025
BOSTON, Massachusetts, March 11 [Category: BizLaw/Legal] -- Goodwin, a law firm, issued the following news release:
* * *
2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share
The M&A team advised 2seventy bio (Nasdaq: TSVT) in its definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) ("BMS") will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash transaction. . . .
* * *
2seventy bio To Be Acquired by Bristol Myers Squibb for $5.00 per Share
The M&A team advised 2seventy bio (Nasdaq: TSVT) in its definitive merger agreement under which Bristol Myers Squibb (NYSE: BMY) ("BMS") will acquire all of the outstanding shares of 2seventy bio at a price of $5.00 per share in an all-cash transaction. . . .